Status:
RECRUITING
Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE)
Lead Sponsor:
Hanoi Obstetrics and Gynecology Hospital
Collaborating Sponsors:
Hôpital Necker-Enfants Malades
Conditions:
Prenatal Infection
Congenital Infection
Eligibility:
All Genders
18+ years
Brief Summary
To estimate the prevalence of congenital CMV infection in Vietnamese neonates and relating morbidity within 2-year follow-up. Along with evaluating the predictive value of the presence and the level o...
Detailed Description
Congenital cytomegalovirus infection (cCMV) is the main non-genetic cause of sensorineural hearing loss (SNHL), and a major cause of neuro-disability. High maternal CMV prevalence seems to be consiste...
Eligibility Criteria
Inclusion
- Vietnamese pregnant women in the first trimester of pregnancy and at delivery and subsequent live neonates at birth.
- Informed consent
Exclusion
- Women under 18 years old.
- Miscarriages
- Stillbirths
- Premature delivery before 34th gestational week
- Loss to follow-up maternal monitoring.
- Participation in another interventional study that influences management of labour at delivery or perinatal morbidity or mortality.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04822142
Start Date
April 1 2022
End Date
June 1 2026
Last Update
March 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanoi Obstetrics and Gynecology Hospital
Hanoi, Vietnam, 100000